What therapies have replaced rofecoxib in Ireland?

British Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2007, Pages 536-541

  Teeling, Mary ^a   O'Connor, Humphrey ^b   Feely, John ^a   Bennett, Kathleen ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b The Adelaide and Meath Hospitals incorporating the National Childrens Hospital   (Ireland)

Author keywords

Co prescription; COX 2 inhibitors; NSAIDs; Proton pump inhibitors; Rofecoxib

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 1 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; ROFECOXIB;

ADOLESCENT; ADULT; ARTICLE; DRUG MARKETING; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; IRELAND; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; CYCLOOXYGENASE 2 INHIBITORS; DRUG UTILIZATION; FEMALE; HUMANS; IRELAND; LACTONES; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PROTON PUMP INHIBITORS; SULFONES;

EID: 34548623609     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02918.x     Document Type: Article

References (23)

1. Bennett K, Teeling M, Feely J. 'Selective' switching from non-selective to selective non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 2003 59 : 645 9.
2. Teeling M, Bennett K, Feely J. Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs? Br J Clin Pharmacol 2004 57 : 337 43.
3. ®. Notification letter on the internet. Available at http://www.vioxx.com/vioxx/ documents/english/hcp_notification_physicians.pdf Last accessed 12 December 2006.
4. EMEA Statement Following Withdrawal of Vioxx (Rofecoxib), 6 October 2004. Press release on the internet. Available at http://www.emea.europa.eu/pdfs/ human/press/pr/9794904en.pdf Last accessed 12 December 2006.
5. ®, 30 September 2004. Press release on the internet. Available at http://www.imb.ie/ uploads/documents/7483372_vioxx.pdf Last accessed 12 December 2006.
6. European Medicines Agency Announces Regulatory Action on COX-2 Inhibitors, 17 February 2005. Public statement on the internet. Available at http://www.emea.eu.int/pdfs/human/press/pr/6275705en.pdf Last accessed 12 December 2006.
7. National Shared Services Primary Care Reimbursement Services. Annual Report 2005. Available at http://www.hse.ie/en/Publications/ NSSPCRSStatisticAlanalysis2005/FiletoUpload,4229,en.pdf Last accessed 12 December 2006.
8. Feely J, Chan R, McManus J, O'Shea B. The influence of hospital-based prescribers on prescribing in General Practice. Pharmacoeconomics 1999 16 : 175 81.
9. ATC Index with DDD's. Oslo : WHO Collaborating Centre for Drug Statistics Methodology 2003.
10. Usher C, Teeling M, Bennett K, Feely J. Effect of clinical trial publicity on HRT prescribing in Ireland. Eur J Clin Pharmacol 2006 62 : 307 10.
11. Abramowicz M, ed. Drugs for Pain. Medical Letter 2000 42 : 73 4.
12. Bjordal JM, Ljunggren AE, Klovning A, Slordal L. NSAIDs, including COX-2 inhibitors in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004 329 : 1317 20.
13. Wood J. Osteoarthritis and its management. Pharm J 1999 7046 : 744 6.
14. Loeser J, Melzack R. Pain: an overview. Lancet 1999 353 : 1607 9.
15. Topol E. Failing the public health - rofecoxib, Merck, and the FDA. N Engl J Med 2004 351 : 17078 80.
16. Dieppe PA, Ebrahim S, Martin RM, Juni P. Lessons from the withdrawal of rofecoxib. BMJ 2004 329 : 867 8.
17. Hawkey CJ. COX-2 inhibitors. Lancet 1999 353 : 307 14.
18. Moore RA. The hidden costs of arthritis treatment and the cost of new therapy - the burden of non-steroidal anti-inflammatory drug gastropathy. Rheumatology 2002 41 (Suppl. 1 7 15.
19. NICE Appraisal Team. The Clinical Effectiveness and Cost-Effectiveness of Celecoxib, Rofecoxib, Meloxicam and Etodolac (COX-2 Inhibitors) for Rheumatoid Arthritis and Osteoarthritis. London : National Institute for Clinical Excellence 2000. Available at http://www.nice.org.uk Last accessed 12 December 2006.
20. Nimesulide. Irish Medicines Board Drug Safety Newsletter 1999; Issue no. 9. Available at http://www.imb.ie/uploads/publications/9385637_Issue%209.pdf Last accessed 12 December 2006.
21. Let the Facts Speak for Themselves. Company Prescribing Information for Aulin (Nimuslide 100 mg). Dublin : Helsinn Birex Pharmaceuticals 1999.
22. Walker AM, Chan K-WA, Yood RA. Patterns of interchange in the dispensing of non-steroidal anti-inflammatory drugs. J Clin Epidemiol 1992 45 : 187 95.
23. Langman M, Kahler KH, Kong SX, Zhang Q, Finch E, Bentkover JD, Stewart EJ. Drug switching patterns among patients taking non-steroidal anti-inflammatory drugs: a retrospective cohort study of a general practitioners database in the United Kingdom. Pharmacoepidemiol Drug Safety 2001 10 : 517 24.